6/21/2023 0 Comments Ancora memory careOn the one side, the memory of the Shoah focuses on some “objects” or global cultural “events,” which spread out contemporaneously in diverse national backgrounds and whose success alternated or was integrated according to common patterns on the other hand, the modalities of importation or exportation of these same objects varies according to national frameworks, while their meanings are connoted with specific details. 1 In parallel, historians have begun to interrogate the conditions that made possible the consolidation of so peculiar a cultural formation, namely a “collective memory.” The Israeli data analyzed by Tom Segev, the French data analyzed by Annette Wieviorka, and the United States data analyzed by Peter Novick 2-to cite only the seminal works of this historical trend-have shown how, in each of the different case studies, this process has evolved along two parallel trajectories. There is no cure for heart failure or FMR and about half of people who develop heart failure die within five years of diagnosis.Over the past twenty years, memorializing the Nazi persecution and extermination of Jews and other minority groups has become in many countries a civic duty supported by governmental institutions. Heart failure and FMR patients suffer from debilitating symptoms such as persistent exhaustion, trouble breathing, confusion and loss of memory. Up to 74% of people with heart failure also suffer from FMR, a condition caused when the left ventricle of the heart becomes enlarged to the point where it pulls the mitral valve leaflets apart and allows blood to flow backwards into the left atrium. The technology of AccuCinch is different from the present technologies which replicate surgical procedures to replace or repair an otherwise normal mitral valve, AccuCinch has been designed to repair the left ventricle directly to enable proper mitral valve function.Ībout 6.5 million US adults have heart failure, a condition where heart’s muscles slowly weaken and lose their ability to pump enough oxygen-rich blood to the body. The minimally invasive procedure has been designed to reduce the size of the left ventricle, improve left ventricular function and reduce symptoms of heart failure.Īncora Heart stated that the AccuCinch therapy has the potential to treat heart failure and FMR patients in whom the disease has advanced beyond the situation where medications and pacemakers can manage the symptoms or for whom the risks of open-heart surgery are too high. The AccuCinch procedure is claimed to directly repair the enlarged left ventricle, which is the underlying cause of heart failure. “We are encouraged by our early clinical experience and interest from new heart centers to participate in the study.” The company’s move follows approval from the US Food and Drug Administration to enroll a second group of subjects and extend to 15 heart centers across the country.Īncora Heart president and CEO Jeff Closs said: “We are pleased that the FDA has approved expansion of this study, as it will allow us to continue to gather valuable clinical information about AccuCinch. The investigational AccuCinch ventricular repair system is designed for the treatment of heart failure and functional mitral regurgitation (FMR). Ancora Heart has expanded enrollment of US early feasibility study for the AccuCinch System for left ventricular repair.
0 Comments
Leave a Reply. |